<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the clinical effects of Yishen Shengxue tablet (YSSXT) on <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:hpo ids='HP_0000001'>All</z:hpo> patients were divided into two groups by simple randomized methods, 106 patients of the treatment group were treated with YSSXT, 36 patients of the control groups were treated with Renshen Guipi Pill (RSGPP) </plain></SENT>
<SENT sid="2" pm="."><plain>Peripheral blood and bone marrow of the two groups of patients were measured before and after treatment </plain></SENT>
<SENT sid="3" pm="."><plain>The toxicity and side effects of YSSXT were also observed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The basical cure rate, remission rate, total effective rate of the treatment and control groups were 23.6%, 36.8%, 82.1% and 11.1%, 22.2%, 58.3% respectively </plain></SENT>
<SENT sid="5" pm="."><plain>There was significant difference between the two groups (P &lt; 0.05 and P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The effect of treatment group was obviously better than that of control group </plain></SENT>
<SENT sid="7" pm="."><plain>Follow up study showed that from <z:hpo ids='HP_0003674'>onset</z:hpo> of the disease to follow up time in the treatment group, the longest one was 18 years 4 months, so the long-term curative effect is promising </plain></SENT>
<SENT sid="8" pm="."><plain>During the period of clinical observation, no obvious side effect and toxicity of YSSXT were found </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: YSSXT is an effective and safe drug in treating <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>It has a good prospect and application </plain></SENT>
</text></document>